Belvedere Trading LLC Protagonist Therapeutics, Inc Call Options Transaction History

Belvedere Trading LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Oct 30, 2024	SELL	$33.72 - $47.33 $60,696 - $85,194	-1,800 Reduced 28.13%	4,600 $206,000
Q2 2024 Nov 01, 2024	BUY	$24.66 - $34.8 $44,388 - $62,639	1,800 Added 39.13%	6,400 $221,000
Q2 2024 Aug 09, 2024	BUY	$24.66 - $34.8 $157,824 - $222,719	6,400 New	6,400 $221,000
Q2 2023 Aug 08, 2023	SELL	$18.02 - $29.36 $174,794 - $284,792	-9,700 Reduced 57.4%	7,200 $198,000
Q1 2023 May 15, 2023	BUY	$10.78 - $25.38 $182,182 - $428,922	16,900 New	16,900 $388,000
Q2 2022 Jul 21, 2022	BUY	$7.06 - $25.52 $118,608 - $428,736	16,800 New	16,800 $172,000

248

56.7M

76.3K

114K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $1.93B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.